CDKN2A and neoplasm: Instead, genomic analysis has revealed genetic deletions in MPM largely in genes considered to be tumor suppressive, such as P16/CDKN2A and NF2 (Jaurand and Fleury‐Feith, 2005), which are not easily targetable.